Rep. Lisa C. McClain Purchases Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI)

Key Points

• Representative Lisa C. McClain purchased between $1,001 and $15,000 in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) on July 22nd as disclosed on August 13th.
• Merit Medical Systems reported a 13.2% revenue increase year-over-year, with a quarterly revenue of $382.46 million and earnings per share of $1.01, surpassing expectations.
• Institutional investors hold 99.66% of Merit Medical Systems' shares, indicating strong backing from significant financial players.

Representative Lisa C. McClain (R-Michigan) recently bought shares of Merit Medical Systems, Inc. NASDAQ: MMSI. In a filing disclosed on August 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in Merit Medical Systems stock on July 22nd. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
• Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.

Merit Medical Systems Stock Performance

Shares of Merit Medical Systems stock traded up $0.21 on Wednesday, reaching $87.36. 672,916 shares of the stock were exchanged, compared to its average volume of 655,513. The business has a 50 day moving average price of $88.94 and a two-hundred day moving average price of $95.40. The firm has a market capitalization of $5.17 billion, a price-to-earnings ratio of 44.35, a PEG ratio of 2.82 and a beta of 0.66. Merit Medical Systems, Inc. has a twelve month low of $81.04 and a twelve month high of $111.45. The company has a quick ratio of 2.66, a current ratio of 4.09 and a debt-to-equity ratio of 0.49.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The medical instruments supplier reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.85 by $0.16. Merit Medical Systems had a net margin of 8.31% and a return on equity of 15.07%. The company had revenue of $382.46 million for the quarter, compared to the consensus estimate of $372.47 million. During the same quarter in the prior year, the company earned $0.92 EPS. Merit Medical Systems's quarterly revenue was up 13.2% on a year-over-year basis. Analysts anticipate that Merit Medical Systems, Inc. will post 3.37 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Merit Medical Systems

A number of large investors have recently bought and sold shares of the business. Maseco LLP acquired a new stake in Merit Medical Systems in the second quarter valued at approximately $28,000. Opal Wealth Advisors LLC purchased a new position in shares of Merit Medical Systems during the 1st quarter valued at approximately $31,000. IFP Advisors Inc grew its stake in Merit Medical Systems by 1,435.0% in the 1st quarter. IFP Advisors Inc now owns 307 shares of the medical instruments supplier's stock valued at $32,000 after acquiring an additional 287 shares during the period. MassMutual Private Wealth & Trust FSB grew its stake in Merit Medical Systems by 55.6% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 375 shares of the medical instruments supplier's stock valued at $35,000 after acquiring an additional 134 shares during the period. Finally, Northwestern Mutual Wealth Management Co. increased its holdings in Merit Medical Systems by 119.8% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 367 shares of the medical instruments supplier's stock worth $39,000 after acquiring an additional 200 shares in the last quarter. Institutional investors and hedge funds own 99.66% of the company's stock.

Analysts Set New Price Targets

A number of analysts have recently weighed in on MMSI shares. Needham & Company LLC reissued a "buy" rating and set a $108.00 target price on shares of Merit Medical Systems in a report on Friday, July 18th. Piper Sandler cut their price target on Merit Medical Systems from $110.00 to $105.00 and set an "overweight" rating on the stock in a research report on Thursday, July 31st. Barrington Research reissued an "outperform" rating and issued a $103.00 price objective on shares of Merit Medical Systems in a report on Thursday, July 31st. Wells Fargo & Company lowered their target price on Merit Medical Systems from $108.00 to $100.00 and set an "overweight" rating on the stock in a research note on Thursday, July 31st. Finally, Robert W. Baird reduced their price target on Merit Medical Systems from $111.00 to $110.00 and set an "outperform" rating for the company in a research report on Friday, April 25th. Eight analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $107.00.

Insider Activity at Merit Medical Systems

In related news, CFO Raul Jr. Parra sold 15,181 shares of the company's stock in a transaction dated Friday, June 13th. The shares were sold at an average price of $93.75, for a total transaction of $1,423,218.75. Following the completion of the transaction, the chief financial officer owned 24,201 shares in the company, valued at $2,268,843.75. This represents a 38.55% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Lynne N. Ward sold 2,433 shares of the firm's stock in a transaction dated Monday, August 11th. The shares were sold at an average price of $84.89, for a total transaction of $206,537.37. Following the completion of the transaction, the director directly owned 12,809 shares in the company, valued at $1,087,356.01. This represents a 15.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 66,779 shares of company stock valued at $6,327,983 in the last three months. Company insiders own 3.70% of the company's stock.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.